SCHEMBL24601326

SCHEMBL24601326

c1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)c1c3c4cc(-n5c6ccccc6c6ccccc65)ccc4n4c5ccc(-n6c7ccccc7c7ccccc76)cc5c(c5c6cc(-n7c8ccccc8c8ccccc87)ccc6n2c15)c34

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ATM Q13315 1/20 0.48
POLB P06746 2/20 0.36
GPR3 P46089 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
LMNA P02545 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
PTPN1 P18031 2/20 0.32
ALDH1A1 P00352 5/20 0.32
HDAC4 P56524 1/20 0.31
HPGD P15428 4/20 0.31
MEN1 O00255 3/20 0.31
MAPT P10636 3/20 0.31
HTT P42858 3/20 0.31
KMT2A Q03164 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22178730 0.98 KDM4E (0.47) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL22178604 0.88 KDM4E (0.47) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL24601325 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL25635029 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL17146719 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL25635031 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL25635028 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL20086174 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL17146741 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3
SCHEMBL12521348 0.86 KDM4E (0.48) KDM4EL3MBTL1ATMPOLBGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 KDM4E 3163/4885L3MBTL1 2377/4885ATM 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.